toxylact: a06ad65 macrogol combinations

The first professional lActological database in the word

Drugs in class A06AD65 (macrogol, combinations) are osmotically acting laxatives based on polyethylene glycol (macrogol) combined with electrolytes, and are considered compatible with breastfeeding because systemic absorption of macrogol is negligible and transfer into milk is not expected.medpedia.framar+7

Pharmacological class and composition

A06AD65 includes macrogol (polyethylene glycol 3350 or 4000) in fixed combination with electrolytes such as sodium chloride, potassium chloride, sodium bicarbonate or sodium sulfate.atcddd.fhi+4
These products are formulated as powders for oral solution used either for short‑term treatment of constipation or, more commonly, for bowel cleansing before colonoscopy and other endoscopic or radiologic procedures.drugsporphyria+2

Mechanism of action

Macrogol is a high‑molecular‑weight polymer that is not absorbed from the gastrointestinal tract and remains confined to the intestinal lumen.ncbi.nlm.nih+2
By binding water and increasing the volume of luminal fluids, it exerts an osmotic effect that enhances colonic peristalsis, softens the stool and facilitates defecation or rapid bowel cleansing depending on the dosage regimen.geneesmiddeleninformatiebank+3

Indications in adults

In lower doses, macrogol–electrolyte preparations are indicated for short‑term treatment of chronic constipation, including in patients with fecal impaction.medpedia.framar+2
In higher doses, they are widely used for full bowel preparation prior to colonoscopy, barium enema examinations or colorectal surgery, where complete evacuation of colonic contents is required.breastfeeding-and-medication+3

Pharmacokinetics relevant to lactation

Polyethylene glycol (macrogol) is very poorly absorbed orally; it is excreted unchanged in the feces, and systemic exposure after therapeutic doses is negligible.drugsporphyria+3
Because it does not reach clinically significant plasma concentrations, passage into breast milk is not expected, and major reference sources consider macrogol‑based laxatives a preferred option in breastfeeding women.drugs+4

Maternal toxicity and adverse effects

Macrogol combinations are generally well tolerated, but gastrointestinal adverse reactions are frequent, especially during high‑volume bowel prep: abdominal distension, cramping, nausea, vomiting and diarrhea.mims+3
Excessive diarrhea may cause transient loss of water and electrolytes; rare but serious events such as electrolyte imbalance, dehydration, hyponatremia or intestinal perforation have been reported mainly in vulnerable patients or when instructions are not followed.analesdepediatria+3

Lactation safety and infant risk

Multiple lactation sources emphasize that macrogol‑based bowel preparations and laxatives can be used while breastfeeding without the need to interrupt nursing, because the drug acts locally in the gut and does not enter breast milk.breastfeedingnetwork+3
No adverse effects have been reported in breastfed infants whose mothers received macrogol combinations at therapeutic doses; infant exposure is considered negligible, and routine monitoring beyond usual clinical observation is not required.geneesmiddeleninformatiebank+3

Considerations for electrolyte components

The associated electrolytes (sodium, potassium, bicarbonate, sulfate, chloride) are present in quantities designed to maintain or restore fluid and electrolyte balance during intensive bowel cleansing.farmacotherapeutischkompas+3
In healthy breastfeeding women, these ions do not pose specific risks to the infant, but maternal conditions such as renal impairment, cardiac failure or pre‑existing electrolyte disturbances warrant caution and possible dose adjustment.mayoclinic+3

Use during pregnancy and postpartum

SmPC and clinical guidance documents state that clinically relevant systemic exposure to macrogol is negligible, and therefore no harmful effects during pregnancy and postpartum are anticipated at recommended doses.drugs+2
Although animal data show some indirect reproductive toxicity at very high, maternally toxic doses, human experience has not identified teratogenicity or specific perinatal risks when macrogol combinations are used appropriately.geneesmiddeleninformatiebank+1

Clinical recommendations in breastfeeding women

For routine constipation in breastfeeding mothers, standard doses of macrogol‑electrolyte laxatives can be used as first‑line osmotic agents, with attention to adequate oral hydration and to any underlying comorbidities.ncbi.nlm.nih+2
For bowel preparation before colonoscopy or similar procedures, several breastfeeding‑focused resources explicitly state that mothers may continue breastfeeding as usual during and after macrogol‑based regimens, while being counselled about transient maternal dehydration, fatigue or sedation from co‑administered drugs.s895428841.websitehome+2

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.